SEC Form 4 · accession 0001144204-15-034486
PALISADE BIO, INC. · PALI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Scott Varde Ogilvie
Director
Period of report
May 22, 2015
Accepted (ET)
May 29, 2015 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001357459
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 22, 2015 | M | 60,000 | $1.32 | A | 80,837 | D | |
| Common StockF1 | May 22, 2015 | F | 48,293 | $1.64 | D | 32,544 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock purchase optionF2 | $1.32 | May 22, 2015 | M | 60,000 | D | May 28, 2008 | May 28, 2015 | Common Stock | 60,000 | 0 | D |
Explanation of responses
- F1Represents 48,293 shares withheld by the Issuer at the market price of $1.64 per share less an exercise price of $1.32 per share to fund the cashless exercise of 60,000 options. The total number of shares issued to Reporting Person pursuant to the cashless exercise of the options is 11,707.
- F2Represents options issued pursuant to Issuer's 2007 Equity Compensation Plan and in compliance with its non-executive director compensation plan. The option was exercised on a cashless basis on 5/22/2015.